Log in
Login
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Bristol-Myers Squibb Co    BMY

Delayed Quote. Delayed  - 05/27 08:02:03 pm
71.03 USD   +0.42%
05/23DJSAMSUNG ELECTRO : Targets U.S. Drug Market With Remicade Knockoff
05/23 BRISTOL MYERS S : to Hold Investor Teleconference to Discuss ASCO Hi..
05/20 INOVALON : Announces Agreement with Bristol-Myers Squibb to Focus on..
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Bristol-Myers Gets SEC Subpoena In Foreign Bribery Probe

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/26/2012 | 07:01pm CEST
   By Peter Loftus 
   Of  
 

Drug maker Bristol-Myers Squibb Co. (>> Bristol Myers Squibb Co.) said it has received a subpoena from the U.S. Securities and Exchange Commission as part of an investigation into bribery overseas.

Bristol-Myers said the subpoena received in March seeks information related to sales and marketing practices in "various countries."

The New York-based company said in a quarterly report filed Thursday with the SEC that it was cooperating with the government. A spokeswoman declined comment beyond the information in Thursday's SEC filing.

Bristol-Myers, which sells the anti-clotting drug Plavix, previously disclosed that the SEC was investigating the activities of the company's units in Germany, concerning potential violations of the U.S. Foreign Corrupt Practices Act, or FCPA.

U.S. authorities in recent years have stepped up enforcement of the FCPA, which bars U.S. companies from bribing foreign officials to obtain or retain business. Multinational drug and medical-device makers based in the U.S. have been among the targets of enforcement.

Last year, Johnson & Johnson (>> Johnson & Johnson) agreed to pay nearly $80 million to resolve allegations that it paid bribes to doctors in three European countries, as well as kickbacks to Iraq to illegally obtain business under former leader Saddam Hussein.

Other drug makers--including Pfizer Inc. (>> Pfizer Inc.), Merck & Co. (>> Merck & Co., Inc.) and Eli Lilly & Co. (>> Eli Lilly & Co.)--also have been the subjects of federal inquiries regarding the FCPA.

-By Peter Loftus, Dow Jones Newswires; +1-215-982-5581; peter.loftus@dowjones.com

share with twitter share with LinkedIn share with facebook
share via e-mail
0
React to this article
Latest news on BRISTOL-MYERS SQUIBB CO
05/23DJSAMSUNG ELECTRONICS : Targets U.S. Drug Market With Remicade Knockoff
05/23 BRISTOL MYERS SQUIBB : to Hold Investor Teleconference to Discuss ASCO Highlight..
05/20 INOVALON : Announces Agreement with Bristol-Myers Squibb to Focus on Real World ..
05/19 BRISTOL MYERS SQUIBB : and AbbVie Announce European Commission Approval of Empli..
05/19 BRISTOL MYERS SQUIBB : Trademark Application for "REAL-WORLD DATA ACROPOLIS" Fil..
05/19DJMERCK : New Hope for Melanoma Patients -- Update
05/18 BRISTOL MYERS SQUIBB : Two-Year Overall Survival Data from Two Pivotal Opdivo® (..
05/18DJMERCK : New Hope for Melanoma Patients
05/18 BRISTOL MYERS SQUIBB : FDA OKs immunotherapy drugs for bladder, blood cancers
05/18 BRISTOL MYERS SQUIBB : Breadth and Depth of Bristol-Myers Squibb’s Immuno-..
Advertisement
News chart
Full-screen chart
Income Statement Evolution
More Financials